Authors

• Malou C. P. Kuppen (ORCID: https://orcid.org/0000-0001-8908-1684)
• Ulrike Haug (ORCID: https://orcid.org/0000-0002-1886-2923)
• David Martínez (ORCID: https://orcid.org/0000-0001-7001-7674)
• Zdravko P. Vassilev (ORCID: https://orcid.org/0000-0002-4902-6784)
• Peter Iversen (ORCID: https://orcid.org/0000-0003-2455-5142)
• Astrid Kousholt
• Jann Mortensen (ORCID: https://orcid.org/0000-0002-1399-8995)
• Bianca Kollhorst (ORCID: https://orcid.org/0000-0001-5964-954X)
• D. Andries Bosch (ORCID: https://orcid.org/0009-0008-5354-8279)
• Federica Pisa (ORCID: https://orcid.org/0000-0003-0459-2616)
• Rachel Weinrib (ORCID: https://orcid.org/0000-0002-7753-0996)
• Véra Ehrenstein (ORCID: https://orcid.org/0000-0002-3415-3254)

Institutions

• Radboud University Nijmegen (NL)
• Bayer (United States) (US)
• Maastricht University Medical Centre (NL)
• Aarhus University Hospital (DK)
• Copenhagen University Hospital (DK)
• Rigshospitalet (DK)
• Radboud University Medical Center (NL)
• Leibniz Institute for Prevention Research and Epidemiology - BIPS (DE)
• RTI Health Solutions (US)
• Maastro Clinic (NL)
• Bayer (Germany) (DE)

Publication Details

Journal

Oncology and Therapy

Published

2025-06-16

DOI

https://doi.org/10.1007/s40487-025-00344-4

Primary Topic

Radiopharmaceutical Chemistry and Applications

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Bayer
• DAK-Gesundheit